Stocks
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, ₹ | ? | 52 642 000 000 | 108 784 000 000 | 108 784 000 000 | 81 049 000 000 | 82 574 000 000 | 80 319 000 000 | ||
| Changes by years, y/y, % | 0% | +107% | 0% | -25% | +2% | +28.5% | |||
Dr. Reddy's Laboratories. EBITDA US GAAP, ₹
Dr. Reddy's Laboratories. EBITDA US GAAP, changes, %
Dr. Reddy's Laboratories. EBITDA US GAAP, sum by quarters, ₹
Dr. Reddy's Laboratories (RDY) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| EBITDA, ₹ | ? | 17 658 000 000 | 22 035 000 000 | 21 286 000 000 | 18 499 000 000 | 18 499 000 000 | 80 319 000 000 | |
| Changes by years, y/y, % | +14% | +13% | +11% | -26% | -26% | |||
| Changes by quarters, q/q, % | -29% | +25% | -3% | -13% | 0% | |||
